:::

詳目顯示

回上一頁
題名:基因及基因醫藥之專利法制發展趨勢
書刊名:法學新論
作者:李素華
作者(外文):Lee, Su-hua
出版日期:2008
卷期:4
頁次:頁53-80
主題關鍵詞:基因發明基因專利基因醫藥試驗免責強制授權研究工具Gene inventionGene patentGenomic medicineResearch exceptionCompulsory licenseResearch tool
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(4) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:4
  • 共同引用共同引用:22
  • 點閱點閱:75
近年來基因工程技術已廣泛應用於人類基因定序、瞭解疾病形成及開發新醫療方法與醫藥。在生醫技術建立全新的產業後,專利制度如何保護基因相關研究成果及基因專利對公共衛生可能產生的不利影響問題,亦為各界所廣泛討論;此等議題涉及專利學說實務與公共衛生政策間之利益平衡。多數國家目前已承認基因發明為專利保護標準,但另一方面則在專利制度新增限制基因及基因醫藥專利權行使之機制,尤其是歐洲國家因落實98/44/EC生技發明保護指令而修正之內國專利法。鑑於我國智慧局亦就生技發明問題提出專利法修正草案,本文擬以基因專利應用於醫藥領域為核心,檢討國外新近修法及實務發展中值得我國借鏡與參考之處。
期刊論文
1.Gitter, Donna M.(2001)。International Conflicts Over Patenting Human DNA Sequences in the United States and the European Union – An Argument for Compulsory Licensing and A Fair-Use Exemption。N.Y.U.L.Rev.,76,1623。  new window
2.李素華(200808)。專利權效力不及之醫藥試驗行爲--評台北地方法院九十三年度智字第七七號與台灣高等法院九十四年度智上字第二六號判決。月旦法學雜誌,159,196-219。  延伸查詢new window
3.李素華(2006)。論強制授權制度在醫藥專利權之適用。生物倫理通訊,21,57-75。  延伸查詢new window
4.張仁平(20050300)。由我國開放用途申請標的論用途發明專利之保護與審查。智慧財產權,75,40-56。new window  延伸查詢new window
5.張仁平(20050400)。由我國開放用途申請標的論用途發明專利之保護與審查。智慧財產權,76,46-78。new window  延伸查詢new window
6.Derzko, Natalie M.(2004)。In Search of a Compromised Solution to the Problem Arising from Patenting Biomedical Research Tools。Santa Clara Computer & High Technology Law Journal,20,347。  new window
7.Eisenberg, Rebecca S.(1987)。Proprietary Rights and the Norms of Science in Biotechnology Research。Yale L. J.,97,177。  new window
8.Faye, David J.(2005)。Exploitation of Research Tools in Plant Biotechnology: Access Through Application of the Experimental Use Exception。BSLR,5,179。  new window
9.Faye, David J.(2005)。Exploitation of Research Tools in Plant Biotechnology: Access through Application of the Experimental Use Exception。BSLR,6,244。  new window
10.Grossman, Steven J.(1990)。Experimental Use or Fair Use as a Defense to Patent Infringement。IDEA,30,243。  new window
11.Hantman, Rolland D.(1985)。Experimental Use as an Exception to Patent Infringement。Journal of the Patent and Trademark Office Society,67,617。  new window
12.Larena, Lorelei Ritchie de(2005)。What Copyright Teaches Patent Law about "Fair Use" and Why Universities are Ignoring the Lesson。OR, L. REV.,84,770。  new window
13.Minwalla, Sherizaan(2002)。A Modest Proposal to Amend the Patent Code 25 U.S.C. § 287 (c) to Allow Health Care Providers to Examine Their Patient's DNA。Southern Illinois University Law Journal,26,471。  new window
14.Pfaff, Esther(2007)。"Bolar" Exemption--A Threat to the Research Tool Industry in the U.S. and the EU?。IIC,258,258-270。  new window
15.O’Rourke, Maureen A.(2000)。Toward a Doctrine of Fair Use in Patent。COLUM. L. REV.,100,1177。  new window
16.Ensthaler, Jürgen、Zech, Herbert(2006)。Stoffschutz bei gentechnischen Patenten-Rechtslage nach Erlass des Biopatentgesetzes und Auswirkung auf Chemiepatente。GRUR,529。  new window
17.Holzapfel, Henrik(2006)。Die patentrechtliche Zulässigkeit der Benutzung von Forschungswerkzeugen。GRUR,10。  new window
18.Rott, Peter(2003)。TRIPS-Abkommen, Menschenrecht, Sozialpolitik und Entwicklungsländer。GRUR,102。  new window
19.Walter, Doris(2007)。Harmonisierung und angemessene Anspruchsbreite bei der Gensequenzpatentierung。GRUR,285。  new window
20.李素華(20070300)。論試驗實施例外及其在醫藥專利權適用之問題。華岡法粹,37,191-229。new window  延伸查詢new window
21.李素華、謝銘洋(20070600)。生技醫療產業所面對新興專利課題--基因檢測、細胞治療與基因 治療之專利保護與權利限制。臺灣科技法律與政策論叢,4(2),49-99。new window  延伸查詢new window
22.Lekovic, Gregory P.(2004)。Genetic Diagnosis and Intellectual Property Rights: A Proposal to Amend "the Physician Immunity Statute"。Yale Journal of Health Policy, Law, and Ethics,4,275。  new window
23.Mandel, Gregory N.(2005)。Promoting Environmental Innovation with Intellectual Property Innovation: A New Basis for Patent Rewards。Temple Journal of Science, Technology & Environmental Law,24,51-69。  new window
24.Heller, Michael A.(1999)。The Boundaries of Private Property。Yale Law Journal,108(5),1163-1223。  new window
25.Mueller, Janice M.(2001)。No "Dilettante Affair": Rethinking The Experimental Use Exception To Patent Infringement For Biomedical Research Tools。Washington Law Review,76(1),1-65。  new window
26.蔡明誠(20010800)。基因技術與發明專利問題。萬國法律,118,45-57。  延伸查詢new window
27.謝銘洋、李素華、宋皇志(20050300)。從歐洲觀點看幹細胞相關發明之可專利性。月旦法學,118,63-89。new window  延伸查詢new window
28.Heller, Michael A.(1998)。The Tragedy of the Anticommons: Property in the Transition from Marx to Markets。Harvard Law Review,111(3),621-688。  new window
29.蔡明誠(20011000)。基因技術與發明專利問題。萬國法律,119,64-72。  延伸查詢new window
研究報告
1.謝銘洋、蔡明誠、李崇僖、李素華(2003)。我國實施WTO與貿易相關智慧財產權協定(TRIPS)對國內智慧財產權發展之影響及未來配合國際智慧財產權發展的因應策略。中華經濟研究院。  延伸查詢new window
2.Dent, Chris、Jensen, Paul、Waller, Sophie、Webster, Beth(2006)。Research Use of Patented Knowledge。  new window
3.(20060110)。Botschaft zur Änderung des Patentgesetzes und zum Bundesbeschluss über die Genehmigung des Patentrechtsvertrags und der Ausführungsordnung。  new window
圖書
1.(2006)。醫藥產業年鑑2005。財團法人生物技術開發中心。  延伸查詢new window
2.Cornish, W, R.、Llewelyn, M.、Adcock, M.(2003)。Intellectual Property Rights (IPRs) and Genetics。  new window
3.Correa, Carlos Maria(2001)。Trends in Drug Patenting。  new window
4.Durham, Alan L.(2004)。Patent Law Essentials: A Concise Guide。Westport, Connecticut:Praeger。  new window
5.Fromm-Russenschuck, Viola、Duggal, Raoul(2004)。WTO und TRIPS。  new window
6.Mueller, Janice M.(2006)。An Introduction to Patent Law。  new window
7.Panos, Institute(2002)。Patents, Pills and Public Health。  new window
8.Sommer, Tine(2007)。The Scope of Gene Patent Protection and the TRIPS Agreement--An Exclusively Nondiscriminatory Approach?。IIC。  new window
9.U.S. NIH(1998)。Working Group on Research Tools。  new window
10.Rudolf, Kraßen(2004)。Patentrecht。  new window
11.Busse, Rudolf(2003)。Patentgesetz: Unter Berücksichtigung des Europäischen Patentübereinkommens und des Patentzusammenarbeitsvertrags。  new window
12.Schulte, Rainer(2005)。Patentgesetz mit Europäischem Patentübereinkommen。  new window
13.Wolfrum, Rüdiger、Stoll, Peter-Tobias、Franck, Stephanie(2002)。Die Gewährleistung freier Forschung an und mit Genen und das Interesse an der wirtschaftlichen Nutzung ihrer Ergebnisse。Frankfurt am Main:Recht & Medizin。  new window
14.Zintler, Mathias(2002)。Die Biotechnologierichtlinie。  new window
15.de Carvalho, Nuno Pires(2005)。The TRIPS Regime of Patent Rights。The Hague:Kluwer Law International Ltd.。  new window
其他
1.「爲硏究或實驗實施其發明」之發明專利權效力不及專利法第57條第1項第2款修法草案公聽會紀錄,http://www.tipo.gov.tw/ch/MultiMedia_FileDownload.ashx?guid=ebl78f5e-2fea-4ec5-8572-7179767bd6f6, 2008/08/25。  延伸查詢new window
2.Lovgren, Stefan(20051013)。One-Fifth of Human Genes Have Been Patented, Study Reveals,http://news.nationalgeographicxom/news/2005/10/1013_51013_gene_patent.html, 2008/08/25。  new window
3.Ravilious, Kate(20051014)。Private Companies Own Human Gene Patents,http://www.guardian.co.Uk/print/0,3858,5309115-10353l,00.html, 2008/08/25。  new window
4.(20060110)。Bundesgesetz über die Erfindungspatente (Patentgesetz, PatG) (Entwurf),http://www.admin.ch/ch/d/ff/2006/155.pdf, 2008/08/24。  new window
圖書論文
1.何建志(200611)。生物技術專利之最適範圍--產業政策與法律分析。生技時代的智慧財產與公共衛生議題。  延伸查詢new window
2.Van Overwalle, Geertrui(2006)。The Implementation of the Biotechnology Directive in Belgium and its After-Effects。The Introduction of a New Research Exemption and a Compulsory Licence for Public Health。IIC。  new window
3.Venter, J. Craig(2000)。Genomic Impact on Pharmaceutical Development。FROM GENOME TO Therapy: Integrating New Technologies with Drug Development。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
QR Code
QRCODE